Premium
O4–05–04: Co–expression of GSK–3β with tau–P301L in double transgenic mice dramatically increases forebrain tauopathy but decreases hindbrain pathology and rescues mortality
Author(s) -
Terwel Dick,
Muyllaert David,
Borghgraef Peter,
Van Leuven Fred
Publication year - 2006
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2006.05.330
Subject(s) - tauopathy , tau protein , genetically modified mouse , biology , gsk 3 , transgene , neuroscience , microbiology and biotechnology , forebrain , phosphorylation , neurodegeneration , pathology , alzheimer's disease , medicine , disease , central nervous system , genetics , gene